Warren Averett Asset Management »

BioCryst Pharmaceuticals shares owned by Warren Averett Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Warren Averett Asset Management from 13F filings

Historical chart of Warren Averett Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Warren Averett Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Warren Averett Asset Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $33k 28k 1.20
2012-12-31 $39k 28k 1.41

More positions owned by Warren Averett Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Rus 1000 Etf (IWB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Invesco Exchange Traded Fd T Ftse Rafi 1500 (PRFZ)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)

View all positions for Warren Averett Asset Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Braidwell
Kynam Capital Management
Deerfield Management Company
Fisher Investments
Two Sigma Investments
Jennifer Ranahan
Two Sigma Advisers
Millennium Management
Norges Bank Investment Management
Rice Hall James & Associates
Balyasny Asset Management
Stifel Financial

View all funds holding BioCryst Pharmaceuticals